This global market research report presents a comprehensive segmentation of the market based on the application (oncology and endocrinology, hepatitis and retrovirus testing, infectious disease testing, GI stool testing, and others) and the product type (instruments and services, and spare parts). The report also provides a market share analysis of the leading companies in this market, including Abbott Diagnostics, Beckman Coulter, bioMerieux, Roche Diagnostics, and Siemens Healthcare.
Technavio’s market research analysts estimate the clinical immunoassay analyzer market in the US to grow at a CAGR of over 6% between 2016 and 2020. Venture capital funding is the driving force for the growth of the medical device industry which is a key factor for next-stage innovations. Attractive venture capitals for small and medium enterprises (SMEs) is the primary driver for the clinical immunoassay analyzer market in the US. The increasing demand for high-throughput screening with the aid of immunoassays and the strong focus on disease management is also expected to augment the growth of this market during the forecast period.
The new market research report from Technavio presents a breakdown and analysis of the clinical immunoassay analyzer segment by product.
“Of late, researchers are working to develop paper-based electrochemical immunoassay devices that can be used for point-of-care testing (POCT) and diagnosis. The use of paper patterning it as a substrate will significantly reduce the price per device. Besides being inexpensive, these tests can also provide quick results. Such paper-based devices can promote development in clinical diagnostics as well,” Barath Palada, Lead Analyst, Pharma, Technavio Research.
The instrument segment dominated the clinical immunoassay analyzer market in the US in 2015, accounting for almost 75% of the overall market share. Immunoassay clinical analyzers such as enzyme immunoassay systems, fluorescence immunoassay systems, immunofluorescence analyzers, CLIA, RIA systems, and nephelometric immunoassay systems, perform automated biochemical tests that detect the presence and concentration of substances in the samples. The instrument segment of the clinical immunoassay analyzer market in the US is expected to grow further during the forecast period due to the increasing popularity of these instruments in small clinical and physician office laboratories.
The key vendors in the clinical immunoassay analyzer market in the US include Abbott Diagnostics, Beckman Coulter, bioMerieux, Roche Diagnostics, and Siemens Healthcare. This market is characterized by the presence of intense competition among several large, medium, and small-sized manufacturers. These vendors form partnerships and provide premium-priced products to maintain their market share. However, since the local vendors in this market offer products at lower prices, they can be a serious threat to large companies.
A more detailed analysis is available on the Technavio report, Clinical Immunoassay Analyzer Maker in the US 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
